<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01531179</url>
  </required_header>
  <id_info>
    <org_study_id>ZTB6303</org_study_id>
    <nct_id>NCT01531179</nct_id>
  </id_info>
  <brief_title>Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants</brief_title>
  <official_title>Role Of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis in Very Low Birth Weight Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zekai Tahir Burak Women's Health Research and Education Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zekai Tahir Burak Women's Health Research and Education Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal
      system and stimulate the immune system. Necrotizing enterocolitis incidence is 10-25% in
      newborn infants whose birth weights are &lt; 1500 g. Although bifidobacterium and other
      lactobacilli spp. have been used to reduce the incidence of necrotizing enterocolitis in
      clinical trials, Lactobacillus reuteri has not been used in the prevention of necrotizing
      enterocolitis in very low birth weight infants yet. The objective of this study is to
      evaluate the efficacy of orally administered Lactobacillus reuteri in reducing the incidence
      and severity of necrotizing enterocolitis in very low birth weight infants.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of Lactobacillus reuteri on necrotizing enterocolitis in VLBW infants</measure>
    <time_frame>up to 6 months</time_frame>
    <description>NEC diagnosis will make modified Bell's criteria. Grade 1A will not include in NEC group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of Lactobacillus reuteri on culture proved sepsis</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Patients with culture positivity will accept as proven sepsis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of Lactobacillus reuteri on weight gain</measure>
    <time_frame>up to 6 months</time_frame>
    <description>The infants will be weight daily on scales that will calibrated weekly.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of Lactobacillus reuteri on length of hospital stay</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Specified length of hospital stay as days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Necrotizing Enterocolitis</condition>
  <condition>Very Low Birth Weight Infants</condition>
  <arm_group>
    <arm_group_label>Lactobacillus reuteri</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lactobacillus reuteri 100 million CFU/day for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactobacillus reuteri</intervention_name>
    <description>Lactobacillus reuteri 100 million CFU/day for 3 months</description>
    <arm_group_label>Lactobacillus reuteri</arm_group_label>
    <other_name>BioGaia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo for 3 months</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Very low birth weight infants &lt; 1500 gr

          -  Gestational age &lt; 32 weeks

        Exclusion Criteria:

          -  Genetic anomalies

          -  Short bowel syndrome

          -  Not willing to participate

          -  Allergy to Lactobacillus reuteri components
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mehmet Yekta Oncel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neonatology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zekai Tahir Burak Maternity Teaching Hospital, Neonatology Unit</name>
      <address>
        <city>Ankara</city>
        <zip>06110</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>http://druginfo.nlm.nih.gov/drugportal/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=drugportal&amp;actionHandle=default&amp;nextPage=jsp/drugportal/ResultScreen.jsp&amp;TXTSUPERLISTID=L040030000&amp;QV1=LACTOBACILLUS+REUTERI</url>
    <description>Lactobacillus reuteri</description>
  </link>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2012</study_first_submitted>
  <study_first_submitted_qc>February 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2012</study_first_posted>
  <last_update_submitted>May 8, 2013</last_update_submitted>
  <last_update_submitted_qc>May 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zekai Tahir Burak Women's Health Research and Education Hospital</investigator_affiliation>
    <investigator_full_name>Mehmet Yekta</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Birth Weight</mesh_term>
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Enterocolitis, Necrotizing</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

